Core Insights - Dana Biotech (920009) experienced significant trading activity on November 12, 2025, with a turnover rate of 39.96% and a trading volume of 2.877 million shares, amounting to a transaction value of 240 million yuan [1][2]. Trading Activity Summary - The top buying seat was an institutional account, purchasing approximately 8.78 million yuan worth of shares, while the top selling seat was from Northeast Securities, selling about 6.01 million yuan [1][2]. - Other notable buying activities included: - Guojin Securities Shenzhen branch: 8.12 million yuan - Guoxin Securities Shenzhen Hongling Middle Road: 3.64 million yuan - Dongfang Securities Chengdu Tianfu Second Street: 3.52 million yuan [2]. - Significant selling activities included: - Guoxin Securities Guangxi branch: 3.16 million yuan - CITIC Securities Beijing Wangjing branch: 2.79 million yuan - Shenwan Hongyuan Securities Guangdong Shenzhen branch: 2.41 million yuan [2].
机构席位买入878.05万 北交所上市公司丹娜生物登龙虎榜